CEVEC is a center of expertise for the production of biopharmaceuticals using a unique human cell-based expression system.
CEVEC offers fully scalable production of viral vectors using its CAP-GT suspension cell platform, including a stable, helper virus-free CAP-GT AAV packaging cell line. The CAP-GT viral packaging cell lines enable easy scale-up and competitive production costs when compared to adherent cell culture systems. CAP-GT suspension cell lines grow to high cell densities and show excellent productivity for a broad range of viruses. Gene therapy vectors such as lentivirus (LV), adenovirus (AV) and adeno-associated virus (AAV) can be produced at industrial scale.)